Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary aldosteronism.

Carlos E Fardella1, Lorena Mosso

  • 1Department of Endocrinology, Faculty of Medicine, Catholic University of Chile, Santiago. cfardella@med.puc.cl

Clinical Laboratory
|April 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-renin hypertension in incidental adrenal adenomas and response to aldosterone-targeted therapy: a prospective study.

European journal of internal medicine·2026
Same author

Persistent elevated thyroglobulin revealing Struma ovarii in a patient treated for papillary thyroid carcinoma: A case report.

Medwave·2026
Same author

ThyroidPrint: Thyroid Genetic Classifier Long-Term Follow-Up of Benign Called Lesions.

Clinical endocrinology·2026
Same author

Adipocyte extracellular vesicles (AdEVs) promote a proinflammatory and profibrotic profile in human renal and endothelial cells in vitro.

International journal of obesity (2005)·2026
Same author

Differentiated high-grade thyroid carcinoma (DHGTC): clinicopathological analysis of a new entity in a chilean center.

Endocrine·2026
Same author

Driving hypertension: non-classic apparent mineralocorticoid excess.

Nature reviews. Endocrinology·2025

Primary aldosteronism, a curable hypertension cause, affects nearly 10% of hypertensive patients. Newer screening methods reveal a higher prevalence than previously thought, highlighting the need for accurate diagnosis and subtype differentiation.

Area of Science:

  • Endocrinology
  • Hypertension Research
  • Clinical Medicine

Background:

  • Primary aldosteronism is an underdiagnosed cause of potentially curable hypertension.
  • Recent studies indicate a prevalence of up to 10% in hypertensive populations, significantly higher than previously estimated using hypokalemia screening.
  • Idiopathic aldosteronism and aldosterone-producing adenoma are the most frequent subtypes.

Purpose of the Study:

  • To review updated data on the prevalence of primary aldosteronism.
  • To detail current diagnostic criteria for confirming autonomous aldosterone secretion.
  • To differentiate the clinical, biochemical, and genetic characteristics of primary aldosteronism subtypes.

Main Methods:

  • Review of recent studies utilizing the plasma aldosterone to plasma renin activity ratio for screening.

Related Experiment Videos

  • Analysis of diagnostic criteria to confirm renin-angiotensin system-independent aldosterone secretion.
  • Compilation of clinical, biochemical, and genetic data for various primary aldosteronism subtypes.

    • Main Results:

    • The plasma aldosterone to plasma renin activity ratio identifies a high prevalence (up to 10%) of primary aldosteronism in hypertensive individuals.
    • This prevalence is substantially greater than that detected by traditional hypokalemia screening.
    • Key subtypes include idiopathic aldosteronism, aldosterone-producing adenoma, glucocorticoid-remediable aldosteronism, unilateral/primary adrenal hyperplasia, and adrenal carcinoma.

    Conclusions:

    • Accurate diagnosis of primary aldosteronism is crucial for identifying potentially curable hypertension.
    • Updated screening methods reveal a higher disease burden than previously recognized.
    • Understanding subtype characteristics is essential for appropriate management and differential diagnosis from other hypermineralocorticoid states.